ÂÜÀòÂÒÂ×

Keri Hildick, Ph.D. has served as the Chief Strategy Officer since January 2020. Dr. Hildick previously served as the Head of Business Development from March 2017 to December 2019 and as Business Development Manager from July 2015 to February 2017. Prior to joining Perspectum, Dr. Hildick served as a healthcare analyst at Sociable Pharma Ltd, a pharmaceutical market research company, from May 2014 to July 2015. She also worked as a pharmacology and discovery researcher at GlaxoSmithKline plc, a pharmaceutical company, from 2007 to 2009.

Dr. Hildick received a Ph.D. in Molecular and Cellular Neuroscience from the University of Bristol and a BSc. in Pharmacology with Industrial Experience from the University of Edinburgh.